Cargando…

High expression of P4HA3 in obesity: a potential therapeutic target for type 2 diabetes

The aims of the present study were to evaluate the expression of prolyl 4-hydroxylase subunit alpha 3 (P4HA3) in adipocytes and adipose tissue and to explore its effect on obesity and type 2 diabetes mellitus (T2DM). We initially demonstrated that P4HA3 was significantly upregulated in the subcutane...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuang, Langen, Li, Can, Hu, Xiaolei, Yang, Qingqing, Pei, Xiaoyan, Jin, Guoxi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Divulgação Científica 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377532/ https://www.ncbi.nlm.nih.gov/pubmed/35976267 http://dx.doi.org/10.1590/1414-431X2022e11741

Ejemplares similares

miR-543 regulates high glucose-induced fibrosis and autophagy in diabetic nephropathy by targeting TSPAN8
por: Zhuang, Langen, et al.
Publicado: (2022)

CircHIPK3 Alleviates High Glucose Toxicity to Human Renal Tubular Epithelial HK-2 Cells Through Regulation of miR-326/miR-487a-3p/SIRT1
por: Zhuang, Langen, et al.
Publicado: (2021)

Ubiquitin-Fold Modifier-1 Participates in the Diabetic Inflammatory Response by Regulating NF-κB p65 Nuclear Translocation and the Ubiquitination and Degradation of IκBα
por: Hu, Xiaolei, et al.
Publicado: (2020)

Soluble ST2 is associated with increased carotid intima-media thickness in patients with type 2 diabetes mellitus: A case-control study
por: Hu, Xiaolei, et al.
Publicado: (2020)

Analysis of long non-coding RNA expression profiles in high-glucose treated vascular endothelial cells
por: Xu, Erqin, et al.
Publicado: (2020)

Ubiquitin fold modifier 1 activates NF-κB pathway by down-regulating LZAP expression in the macrophage of diabetic mouse model
por: Hu, Xiaolei, et al.
Publicado: (2020)

Adipokines: Potential Therapeutic Targets for Vascular Dysfunction in Type II Diabetes Mellitus and Obesity
por: El husseny, Mostafa Wanees Ahmed, et al.
Publicado: (2017)

Transient receptor potential vanilloid 4 channels as therapeutic targets in diabetes and diabetes‐related complications
por: Hu, Wei, et al.
Publicado: (2020)

The Role of P4HA1 in Multiple Cancer Types and its Potential as a Target in Renal Cell Carcinoma
por: Li, Yang, et al.
Publicado: (2022)

High expression of CD52 in adipocytes: a potential therapeutic target for obesity with type 2 diabetes
por: Mao, Rui, et al.
Publicado: (2021)

Twincretin as a potential therapeutic for the management of type 2 diabetes with obesity
por: Usui, Ryota, et al.
Publicado: (2019)

Profiling and functional analysis of differentially expressed circular RNAs in high glucose‐induced human umbilical vein endothelial cells
por: Jin, Guoxi, et al.
Publicado: (2019)

mRNAs expression profiles of high glucose-induced memory in human umbilical vein endothelial cells
por: Jin, Guoxi, et al.
Publicado: (2019)

Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics
por: Chaudhry, Gul-e-Saba, et al.
Publicado: (2021)

Effects of the POMC System on Glucose Homeostasis and Potential Therapeutic Targets for Obesity and Diabetes
por: Yang, Dan, et al.
Publicado: (2022)

Anthocyanins: Potential Therapeutic Approaches towards Obesity and Diabetes Mellitus Type 2
por: Franco-San Sebastián, Denise, et al.
Publicado: (2023)

TRP Channels as Therapeutic Targets in Diabetes and Obesity
por: Zsombok, Andrea, et al.
Publicado: (2016)

Bioinformatics analysis of candidate genes and potential therapeutic drugs targeting adipose tissue in obesity
por: Yu, Yun, et al.
Publicado: (2021)

Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy
por: Liu, Na, et al.
Publicado: (2017)

Ion Channels in Obesity: Pathophysiology and Potential Therapeutic Targets
por: Vasconcelos, Luiz H. C., et al.
Publicado: (2016)

Microbiota-Mitochondria Inter-Talk: A Potential Therapeutic Strategy in Obesity and Type 2 Diabetes
por: Vezza, Teresa, et al.
Publicado: (2020)

Epidermal Growth Factor Receptor: A Potential Therapeutic Target for Diabetic Kidney Disease
por: Sheng, Lili, et al.
Publicado: (2021)

PBRM1 presents a potential prognostic marker and therapeutic target in duodenal papillary carcinoma
por: He, Xujun, et al.
Publicado: (2022)

Systematic Analysis of the Expression and Prognostic Significance of P4HA1 in Pancreatic Cancer and Construction of a lncRNA-miRNA-P4HA1 Regulatory Axis
por: Hu, Zhili, et al.
Publicado: (2020)

Serotonin as a New Therapeutic Target for Diabetes Mellitus and Obesity
por: Oh, Chang-Myung, et al.
Publicado: (2016)

Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction
por: Achari, Arunkumar E., et al.
Publicado: (2017)

Hypoxia in Obesity and Diabetes: Potential Therapeutic Effects of Hyperoxia and Nitrate
por: Norouzirad, Reza, et al.
Publicado: (2017)

Adiponectin: The Potential Regulator and Therapeutic Target of Obesity and Alzheimer’s Disease
por: Kim, Jong Youl, et al.
Publicado: (2020)

Pathological Mechanisms and Potential Therapeutic Targets of Pulmonary Arterial Hypertension: A Review
por: Xiao, Ying, et al.
Publicado: (2020)

Proteomics identifies new potential therapeutic targets of diabetic retinopathy
por: Zhou, Huanran, et al.
Publicado: (2022)

Implications of publicly available genomic data resources in searching for therapeutic targets of obesity and type 2 diabetes
por: Jung, Sungwon
Publicado: (2018)

The complex pathophysiology of bone fragility in obesity and type 2 diabetes mellitus: therapeutic targets to promote osteogenesis
por: Bathina, Siresha, et al.
Publicado: (2023)

Therapeutic potential of vasculogenic mimicry in urological tumors
por: Lin, Xinyu, et al.
Publicado: (2023)

Therapeutic Effects of Quercetin on Inflammation, Obesity, and Type 2 Diabetes
por: Chen, Shuang, et al.
Publicado: (2016)

Potential Therapeutic Targeting Neurotransmitter Receptors in Diabetes
por: Pan, Xiaohui, et al.
Publicado: (2022)

Obesity-Related Glomerulopathy: From Mechanism to Therapeutic Target
por: Wei, Lifang, et al.
Publicado: (2021)

Reduced Bone Mass in Collagen Prolyl 4‐Hydroxylase P4ha1 (+/−); P4ha2 (−/−) Compound Mutant Mice
por: Tolonen, Jussi‐Pekka, et al.
Publicado: (2022)

Hepatic Monoacylglycerol O-acyltransferase 1 as a Promising Therapeutic Target for Steatosis, Obesity, and Type 2 Diabetes
por: Hayashi, Yasuhiro, et al.
Publicado: (2014)

MiR-4763-3p targeting RASD2as a Potential Biomarker and Therapeutic Target for Schizophrenia
por: Wang, Jiao, et al.
Publicado: (2022)

Inhibitory G proteins and their receptors: emerging therapeutic targets for obesity and diabetes
por: Kimple, Michelle E, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vnrgbvqar45hdqo6h9lsn00uqh